saCas9 Null Mutant Protein

K046

saCas9 Null Mutant Protein

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The saCas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type saCas9. Such a saCas9 protein retains its ability to bind to genomic DNA through sgRNA:genomic DNA base pairing, however, the saCas9 Null Mutant does not induce cleavage. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria <i>Staphylococcus aureus</i>, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT).

348.5 €

MBS4156507-00065mg

saCas9 Null Mutant Protein

452.75 €

MBS4156507-5x00065mg

saCas9 Null Mutant Protein

988.25 €

MBS389045-001mg

SaCas9 mAb (Clone 11E7), sample

452.75 €

MBS389045-01mg

SaCas9 mAb (Clone 11E7), sample

969.12 €

MBS389045-5x01mg

SaCas9 mAb (Clone 11E7), sample

3697.62 €